(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. p63 and Dlx3 expression in primary mouse keratinocytes
cultured in vitro. Dlx3 (A) and TAp63 (B)
mRNAs were induced, and
Np63 (C) mRNA was downregulated
after 12- and 24-hours of high-[Ca+2] treatment. (D-F) p63
binds to the Dlx3 promoter region in vitro and in vivo. (D) EMSA assay
performed with a DNA fragment that included the Dlx3 p63-binding site 1 and 2
using nuclear extract from primary keratinocytes (NE), and in the presence of
100 M excess of specific (SC) and nonspecific (NC) competitors. (E-F) ChIP
analysis on mouse keratinocytes with either control IgG or p63 antibody (p63
Ab) on the region of the Dlx3 promoter containing the p63-binding
sites by regular (E) and real-time (F) PCR. (G) ChIP analysis on
TAp63
-transfected H1299 cells with no antibody (no Ab) or p63 antibody
on DLX3 and JAG2 promoters. ACHR was used as a control.